Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001342644 | SCV001536588 | uncertain significance | Pancreatic adenocarcinoma | 2020-11-17 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with PALLD-related conditions. This variant is present in population databases (rs755470870, ExAC 0.002%). This sequence change falls in intron 9 of the PALLD gene. It does not directly change the encoded amino acid sequence of the PALLD protein. |
Prevention |
RCV003946004 | SCV004763575 | likely benign | PALLD-related disorder | 2023-08-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |